KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

2,479
Mkt Cap
$3.56B
Volume
12.00
52W High
$49.12
52W Low
$18.26
PE Ratio
62.38
KNSA Fundamentals
Price
$47.02
Prev Close
$46.50
Open
$46.73
50D MA
$43.90
Beta
0.73
Avg. Volume
548,246.10
EPS (Annual)
$0.7471
P/B
6.25
Rev/Employee
$1.85M
$2,853.31
Loading...
Loading...
News
all
press releases
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by Braidwell LP
Braidwell LP reduced its stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 41.7% in the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by ArrowMark Colorado Holdings LLC
ArrowMark Colorado Holdings LLC trimmed its position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 26.9% in the 3rd quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Cut to Hold at Wall Street Zen
Wall Street Zen downgraded Kiniksa Pharmaceuticals International from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·4d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Acquires 101,666 Shares of Kiniksa Pharmaceuticals International, plc $KNSA
Connor Clark & Lunn Investment Management Ltd. boosted its stake in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 16.3% during the 3rd quarter, according to the company in...
MarketBeat·5d ago
News Placeholder
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of "Moderate Buy" from Analysts
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine ratings firms that are presently covering the stock...
MarketBeat·9d ago
News Placeholder
Vanguard Group Inc. Trims Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA
Vanguard Group Inc. cut its holdings in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 2.2% during the 3rd quarter, according to its most recent 13F filing with...
MarketBeat·13d ago
News Placeholder
Fisher Asset Management LLC Acquires 180,029 Shares of Kiniksa Pharmaceuticals International, plc $KNSA
Fisher Asset Management LLC lifted its stake in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA - Free Report) by 176.1% in the third quarter, according to the company in its most recent...
MarketBeat·13d ago
News Placeholder
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded at Zacks Research
Zacks Research upgraded shares of Kiniksa Pharmaceuticals International from a "strong sell" rating to a "hold" rating in a research note on Wednesday...
MarketBeat·19d ago
News Placeholder
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $53.00 Price Target at Wells Fargo & Company
Wells Fargo & Company raised their price objective on shares of Kiniksa Pharmaceuticals International from $50.00 to $53.00 and gave the company an "overweight" rating in a report on Wednesday...
MarketBeat·21d ago
News Placeholder
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $53.00 Price Target at Wedbush
Wedbush increased their target price on shares of Kiniksa Pharmaceuticals International from $50.00 to $53.00 and gave the stock an "outperform" rating in a research report on Wednesday...
MarketBeat·21d ago
<
1
2
...
>

Latest KNSA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.